PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
7,045,522
Share change
-2,293,772
Total reported value
$13,184,000
Price per share
$1.90
Number of holders
25
Value change
-$22,272,669
Number of buys
13
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q4 2016

As of 31 Dec 2016, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,045,522 shares. The largest 10 holders included Abingworth LLP, DEERFIELD MANAGEMENT CO, Pharmstandard International S.A., MPM ASSET MANAGEMENT LLC, BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, Deer VII & Co. Ltd., VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, and FINANCIAL COUNSELORS INC. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.